Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Not Confirmed
Not Confirmed
29-31 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Chemicals AmericaChemicals America
Industry Trade Show
Not Confirmed
29-31 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
28 Aug 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/drugmaker-mundipharmas-china-unit-sale-fails-find-buyer-sources-say-2024-08-28/
13 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/13/2929667/0/en/Cidara-Therapeutics-Provides-Corporate-Update-and-Reports-Second-Quarter-2024-Financial-Results.html
10 May 2024
// CONTRACT PHARMA
https://www.contractpharma.com/contents/view_breaking-news/2024-05-10/mabxience-names-new-chief-executive-officer/?widget=listSection
24 Apr 2024
// BUSINESSWIRE
16 Apr 2024
// BUSINESSWIRE
22 Dec 2023
// BUSINESSWIRE
Inspections and registrations
ABOUT THIS PAGE
Mundipharma is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of FACILITIES AND CONTROLS bulk offered by Mundipharma